Metal Panel Patch Test Study
- Conditions
- Skin rash, EczemaD000066491
- Registration Number
- JPRN-jRCT2031220654
- Lead Sponsor
- Yoshizumi Yuriko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
The study population will consist of two groups of subjects. Group 1 will include the intended population, individuals with suspected allergic contact dermatitis to one or more of the investigational metal allergens. Subjects may have active dermatitis attributable to metal allergy at the time of enrollment or a recent history (within the past 5 years) of dermatitis that is suspected to be due to metal allergy that resolved prior to enrollment due to treatment or elimination of exposure to the suspected metal trigger. Group 2 will include patients without history or symptoms of metal-induced allergic contact dermatitis and without chronic exposure
Participation in SmartPractice dose response study
Breastfeeding or pregnant
Topical treatment with corticosteroids or immunosuppressive agents on or near the test area
Systemic treatment with corticosteroids or immunosuppressive agents
Treatment with UV light
Dermatitis on or near the test area on the back
Known or suspected infection of the skin, joints or other site(s) associated with metal exposure
Fibromyalgia, chronic fatigue, depression, cognitive impairment, flu-like symptoms, diarrhea and/or headache without at least one of the symptoms related to metal exposure
Psoriasis, dermatitis herpetiformis, mycosis fungoides or cutaneous T-cell lymphoma
Inability to comply with patch test study requirements
Participation in an investigational clinical trial 3 weeks prior to inclusion in this study.
An opinion of the Investigator that deems the potential subject is unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method